C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion
- 1 February 2007
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 178 (3) , 1819-1828
Abstract
The complement system is one of the major ways by which the body detects injury to self cells, and the alternative pathway of complement is rapidly activated within the tubulointerstitium after renal ischemia/reperfusion (I/R). In the current study, we investigate the hypothesis that recognition of tubular injury by the complement system is a major mechanism by which the systemic inflammatory response is initiated. Gene array analysis of mouse kidney following I/R initially identified MIP-2 (CXCL2) and keratinocyte-derived chemokine (KC or CXCL1) as factors that are produced in a complement-dependent fashion. Using in situ hybridization, we next demonstrated that these factors are expressed in tubular epithelial cells of postischemic kidneys. Mouse proximal tubular epithelial cells (PTECs) in culture were then exposed to an intact alternative pathway and were found to rapidly produce both chemokines. Selective antagonism of the C3a receptor significantly attenuated production of MIP-2 and KC by PTECs, whereas C5a receptor antagonism and prevention of membrane attack complex (MAC) formation did not have a significant effect. Treatment of PTECs with an NF-κB inhibitor also prevented full expression of these factors in response to an intact alternative pathway. In summary, alternative pathway activation after renal I/R induces production of MIP-2 and KC by PTECs. This innate immune system thereby recognizes hypoxic injury and triggers a systemic inflammatory response through the generation of C3a and subsequent activation of the NF-κB system.Keywords
This publication has 55 references indexed in Scilit:
- Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injuryAmerican Journal of Physiology-Renal Physiology, 2006
- Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusionJournal of Clinical Investigation, 2006
- Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusionKidney International, 2005
- Molecular basis for complement component 6 (C6) deficiency in rats and miceImmunobiology, 2004
- Ischemic acute renal failure: An inflammatory disease?Kidney International, 2004
- T cells as mediators in renal ischemia/reperfusion injuryKidney International, 2004
- The chemokine KC regulates HGF-stimulated epithelial cell morphogenesisAmerican Journal of Physiology-Renal Physiology, 2004
- A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in ratsKidney International, 2003
- Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemiaKidney International, 2001
- The Morphology of “Acute Tubular Necrosis” in ManMedicine, 1979